Skip to main content
Year archive

Prism Medico and Pharmacy Ltd. — 2019 filings

All 84 regulatory filings released by Prism Medico and Pharmacy Ltd. (512217) in 2019, sourced directly from the official regulator.

84 Filings
2019 Period
2019 filings (84)
Filing Released Lang
It may please be noted that in compliance with the SEBI (Prohibition to Insider Trading) Regulations. 2015 as amended by the SEBI (Prohibition of Insider Trading) (Amendment) Regulations, ....
Regulatory Filings
2019-12-31 English
Considered and approve the resignation of Ms. Swati Pandey, Company Secretary and Compliance Officer of the Company w.ef 31st December, 2019.
Regulatory Filings
2019-12-30 English
Considered and approve the resignation of Ms. Swati Pandey, Company Secretary and Compliance Officer of the Company w.ef 31st December, 2019.
Regulatory Filings
2019-12-30 English
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/12/2019 ,inter alia, to consider and approve the resignation ....
Regulatory Filings
2019-12-21 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasjot Singh
Regulatory Filings
2019-12-14 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasjot Singh
Regulatory Filings
2019-12-14 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ajooni Biotech Ltd
Regulatory Filings
2019-12-06 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasjot Singh
Regulatory Filings
2019-11-25 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasjot Singh
Regulatory Filings
2019-11-25 English
SUBMISSION OF STANDALONE AND CONSOLIDATED CASH FLOW FOR THE HALF YEAR ENDED 30th SEPTEMBER, 2019
Regulatory Filings
2019-11-18 English
Dear Sir/Madam, In reference to your mail dated 01.11.2019, enclosing herewith the revised Consolidated Financial Results for the Quarter and Half Year Ended 30th September, 2019 ....
Regulatory Filings
2019-11-02 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasjot Singh
Regulatory Filings
2019-10-29 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasjot Singh
Regulatory Filings
2019-10-29 English
Pursuant to Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we hereby furnish a copy of Compliance Certificate issued by M.R. Chechi & Associates, ....
Regulatory Filings
2019-10-22 English
Dear Sir/Madam Pursuant to Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we are sending herewith a certificate duly signed by Purva Sharegistry ....
Regulatory Filings
2019-10-19 English
Dear Sir, We are furnishing herewith newspaper publication under the provisions of Regulation 47 of SEBI (LODR) Regulations, 2015, in respect of Financial Results for the 30th ....
Regulatory Filings
2019-10-17 English
Dear Sir, Please find attached the UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED 30th SEPTEMBER, 2019 Kindly take the same on record. Thanking You
Regulatory Filings
2019-10-14 English
1.Considered, approved and taken on record the unaudited Standalone and Consolidated Financial Results for the quarter ended 30th September, 2019. 2.Considered and approved the ....
Regulatory Filings
2019-10-14 English
Submission of confirmation certificate as per Regulation 74(5) of Securities and Exchange Board of India (Depositories And Participants) Regulations, 2018 for the Quarter Ended on 30th ....
Regulatory Filings
2019-10-11 English
Dear Sir/Madam We enclose herewith the Statement of Investor Complaints for the quarter ended on 30th September, 2019 pursuant to Regulation 13(3) of the SEBI (LODR) Regulations, 2015 ....
Regulatory Filings
2019-10-07 English
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/10/2019 ,inter alia, to consider and approve 1. To consider, ....
Regulatory Filings
2019-10-05 English
Dear Sir, This has reference with the above mentioned subject, please note that since the Paid Up Equity Share Capital and Net Worth of the Company is less than the prescribed ....
Regulatory Filings
2019-10-04 English
Dear Sir/Madam, This is to inform you that website of Prism Medico and Pharmacy Limited is updated and functional as per Reg. 46 of SEBI (LODR) Regulations, 2015. The website ....
Regulatory Filings
2019-10-04 English
Dear Sir, Please find attached the Revised Voting Result
Regulatory Filings
2019-10-03 English
Dear Sir, Submitting herewith the Scrutinizer''s Report alongwith Voting result.
Regulatory Filings
2019-10-01 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasjot Singh
Regulatory Filings
2019-10-01 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasjot Singh
Regulatory Filings
2019-10-01 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasjot Singh
Regulatory Filings
2019-09-30 English
It may please be noted that in compliance with the SEBI (Prohibition to Insider Trading) Regulations. 2015 as amended by the SEBI (Prohibition of Insider Trading) (Amendment) Regulations, ....
Regulatory Filings
2019-09-30 English
Dear Sir/ Madam, We submit herewith the proceedings of the Annual General Meeting of the Company held on 30th September, 2019. This is for your information and record. ....
Regulatory Filings
2019-09-30 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasjot Singh
Regulatory Filings
2019-09-25 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasjot Singh
Regulatory Filings
2019-09-25 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasjot Singh
Regulatory Filings
2019-09-20 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasjot Singh
Regulatory Filings
2019-09-20 English
We enclose, in terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, copies of the newspaper clippings of the advertisement published on ....
Regulatory Filings
2019-09-06 English
We enclose a copy of the Notice of the Annual General Meeting of the Company for the financial year ended 31st March, 2019 dated 30th August, 2019 convening the 17th Annual General Meeting ....
Regulatory Filings
2019-09-05 English
We enclose a copy of the Report and Accounts of the Company for the financial year ended 31st March, 2019 together with the Notice dated 30th August, 2019 convening the 17th Annual General ....
Regulatory Filings
2019-09-05 English
We enclose a copy of the Report and Accounts of the Company for the financial year ended 31st March, 2019 together with the Notice dated 30th August, 2019 convening the 17th Annual General ....
Regulatory Filings
2019-09-05 English
To close the Register of Members and Share Transfer Books from 24th September, 2019 to 30th September, 2019 (Both days inclusive) for the purpose of AGM, if any, declared by member in the ....
Regulatory Filings
2019-08-30 English
1. Considered and final the date, time and venue of 17th Annual General Meeting to be held on 30th September, 2019 at 10:00 a.m. at Mohali Industries Association, Bay No.143-144 Industrial ....
Regulatory Filings
2019-08-30 English
With reference to our outcome dated 13th August, 2019, we would like to inform you that for the appointment of Secretarial Auditor, we had received two quotations, out of which we had appointed ....
Regulatory Filings
2019-08-29 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasjot Singh
Regulatory Filings
2019-08-22 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasjot Singh
Regulatory Filings
2019-08-22 English
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/08/2019 ,inter alia, to consider and approve 1. To Approve the ....
Regulatory Filings
2019-08-22 English
We are furnishing herewith newspaper publication under the provisions of Regulation 47 of SEBI (LODR) Regulations, 2015, in respect of Financial Results for the 30TH June, 2019 which has ....
Regulatory Filings
2019-08-14 English
Pursuant to the provisions of Regulation 30(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform your ....
Regulatory Filings
2019-08-13 English
Pursuant to the provisions of Regulation 30(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform your ....
Regulatory Filings
2019-08-13 English
The Board Meeting to be held on 13/08/2019 has been revised to 13/08/2019 The Board Meeting to be held on 13/08/2019 has been revised to 13/08/2019
Regulatory Filings
2019-08-09 English
The Board Meeting to be held on 13/08/2019 has been revised to 13/08/2019 The Board Meeting to be held on 13/08/2019 has been revised to 13/08/2019 The Board Meeting to be held on 13/08/2019 ....
Regulatory Filings
2019-08-09 English
The Board Meeting to be held on 13/08/2019 has been revised to 13/08/2019 The Board Meeting to be held on 13/08/2019 has been revised to 13/08/2019
Regulatory Filings
2019-08-09 English
We are furnishing herewith newspaper publication under the provisions of Regulation 47 of SEBI (LODR) Regulations, 2015, in respect of intimation of Board Meeting in which the Financial ....
Regulatory Filings
2019-08-06 English
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2019 ,inter alia, to consider and approve 1.To consider, approve ....
Regulatory Filings
2019-08-05 English
We enclose herewith the Statement of Investor Complaints for the quarter ended on 30th June, 2019 pursuant to Regulation 13(3) of the SEBI (LODR) Regulations, 2015
Regulatory Filings
2019-07-09 English
The website of Prism Medico and Pharmacy Limited is updated and functional as per Reg. 46 of SEBI (LODR) Regulations, 2015. The website address of the Company is www.prismmedico.com
Regulatory Filings
2019-07-09 English
Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we hereby furnish a copy of Confirmation Certificate issued by ....
Regulatory Filings
2019-07-09 English
Trading Window of the Company has been kept closed for Directors, KMPs, designated employees and other connected persons from Monday, the 1st July, 2019 till the end of 48 hours after the ....
Regulatory Filings
2019-07-01 English
Revised outcome. In the previous outcome, there was typographical error of month of Board Meeting. The Board of Directors in their meeting held on Monday, 17th June, 2019 at 2:30 ....
Regulatory Filings
2019-06-17 English
The Board of Directors in their meeting held on Monday, 17th May, 2019: 1. Considered and Approved the resignation of Mr. Jasjot Singh (DIN: 01937631) with effect from 8th June, 2019. ....
Regulatory Filings
2019-06-17 English
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/06/2019 ,inter alia, to consider and approve We wish to inform ....
Regulatory Filings
2019-06-08 English
We are furnishing herewith newspaper publication under the provisions of Regulation 47 of SEBI (LODR) Regulations, 2015, in respect of Financial Results for the Quarter and Year ended on ....
Regulatory Filings
2019-06-03 English
our Company is not required to submit Related Party Transaction disclosure as required by Regulation 23 (9) of The SEBI (LODR) Regulations, 2015 as the paid up share capital of the Company ....
Regulatory Filings
2019-06-03 English
Our Company is not required to submit Related Party Transaction disclosure as required by Regulation 23 (9) of The SEBI (LODR) Regulations, 2015 as the paid up share capital of the Company ....
Regulatory Filings
2019-06-03 English
Dear Sir, The copy of the revised result is attached herewith as some of the pages of the earlier submitted documents were not cleared. Thanking You
Regulatory Filings
2019-05-31 English
Considered and approve Audited Financial Result for 31.03.2019
Regulatory Filings
2019-05-30 English
Pursuant to the provisions of Regulation 30(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform your ....
Regulatory Filings
2019-05-30 English
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2019 ,inter alia, to consider and approve We wish to inform ....
Regulatory Filings
2019-05-29 English
Pursuant to Regulation 29 read with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, it was informed to you vide our intimation dated 20th May, ....
Regulatory Filings
2019-05-23 English
2.Closure of trading window from April 3, 2019 and ending 48 hours after the results are made public on May 29, 2019 (both days inclusive) as per the Securities and Exchange Board of the ....
Regulatory Filings
2019-05-20 English
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2019 ,inter alia, to consider and approve 1.To Consider, Approve ....
Regulatory Filings
2019-05-20 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2019-04-30 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2019-04-30 English
Dear Sir/Madam Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we hereby furnish a copy of Confirmation Certificate ....
Regulatory Filings
2019-04-27 English
Dear Sir/Madam Pursuant to Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we hereby furnish a copy of Compliance Certificate issued by ....
Regulatory Filings
2019-04-27 English
1.Considered and approved the appointment of M/s. Gurdeep Singh & Associates (FRN 013916N) as Internal Auditor of the Company for the financial year 2019-20. 2.Taken on record the ....
Regulatory Filings
2019-04-25 English
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2019 ,inter alia, to consider and approve The appointment ....
Regulatory Filings
2019-04-17 English
Dear Sir/Madam Pursuant to Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we are sending herewith a certificate duly signed by Purva Sharegistry ....
Regulatory Filings
2019-04-08 English
Dear Sir/Madam, This is to inform you that website of Prism Medico and Pharmacy Limited is updated and functional as per Reg. 46 of SEBI (LODR) Regulations, 2015. The website ....
Regulatory Filings
2019-04-06 English
Closure of trading window from April 03, 2019 and ending 48 hours after the results are made public for the quarter and Financial Year ended 31st March, 2019 as per Circular No. LIST/COMP/01/2019-20 .
Regulatory Filings
2019-04-03 English
Closure of trading window from April 03, 2019 and ending 48 hours after the results are made public as per the Circular No. LIST/COMP/01/2019-20 dated April 02, 2019.
Regulatory Filings
2019-04-03 English
1.Considered and approved the appointment of M/s. M R Chechi & Associates as a Secretarial Auditor of the Company for the financial year 2018-19.
Regulatory Filings
2019-03-30 English
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/03/2019 ,inter alia, to consider and approve 1.To Consider and ....
Regulatory Filings
2019-03-26 English
Revised Financial Results for the quarter ended 31st December, 2018
Regulatory Filings
2019-02-21 English
Newspaper Publication of Financial Results for the quarter ended on December 31, 2018, which have been published in the following newspapers: 1. Business Standard (English) dated ....
Regulatory Filings
2019-02-19 English
Newspaper Publication of Financial Results for the quarter ended on December 31, 2018, which have been published in the following newspapers: 1. Business Standard (English) dated 19.02.2019-circulatin
Regulatory Filings
2019-02-19 English